Please join us for the 2024 Cellarity medSCAI Symposium: Medicines, Single Cell and AI
October 22, 2024
11:00AM – 6:00PM
Register Now
"*" indicates required fields
The Theme of this Year’s Symposium is AI Powered Drug Discovery from Data to Clinic
The field has seen tremendous progress in single cell technologies, big data and AI-driven analyses, and there has been widespread adoption of these approaches in biotech and pharma. Despite this tremendous potential, translational impact has been to date been modest. We will address this with presentations and discussions aimed at defining these limitations, finding ways to overcome them and ultimately to maximizing delivery of new drugs to patients.
Agenda
11:00AM
Registration, Welcome, and Lunch
11:30AM
Keynote Address
- Aviv Regev, EVP and Head of Genentech Research and Early Development, “From Cell Atlases to Medicines with AI”
12:45PM
Session 1: From Data to New Biology
- Paul Blainey, Professor, MIT Dept of Biological Engineering, “Scaling up empirical cell biology in the age of computers”
- Joey Azofeifa, CEO, Arpeggio Biosciences, “Massively high throughput transcriptomics discovers a molecular glue degrading NRF2 in lung cancer”
- Cole Trapnell, Professor, University of Washington, “Extracting mechanistic insights from atlas-scale single-cell perturbation experiments”
2:30PM
Session 2: From Biology and Computation to Translation
- Caroline Gubser-Keller, Global Head Data Science, Novartis Institutes for BioMedical Research, “Harnessing AI for Drug Discovery to Accelerate, Enhance, and Innovate”
- Mark Murcko, Dewpoint Therapeutics, “The Evolving Role of Computation in Drug Discovery”
4:00PM
Panel discussion: Identifying and Solving the Hard Challenges to Realizing the Full Translational Impact of AI on Drug Discovery/Development
- Panel will be led by Ryan Cross, Endpoints News
- Jen Nwankwo, Founder & CEO, 1910 Genetics
- Rory Kelleher, Senior Director and Global Head of Business Development, Healthcare and Life Sciences, NVIDIA
- Peter Clark, VP Computation Drug Design, Novo Nordisk
- Cameron Trenor, SVP and Head of Translational Medicine, Cellarity
5:00PM
Networking cocktail hour
Speakers
Aviv Regev
EVP and Head of Genentech Research and Early Development
Paul Blainey
Professor, MIT Biological Engineering; Broad Institute faculty
Joey Azofeifa
CEO Arpeggio Biosciences
Cole Trapnell
University of Washington
Caroline Gubser-Keller
Global Head of Data Science, Discovery Sciences, Novartis Biomedical Research
Mark Murcko
Dewpoint Therapeutics
Jen Nwankwo
Founder & CEO, 1910 Genetics
Cameron Trenor
SVP and Head of Translational Medicine, Cellarity
Ryan Cross
Senior Science Correspondent, Endpoints News
Event Information
Date & Time
October 22, 2024
11:00AM – 6:00PM
Address
101 South Street
Somerville, MA 02143
Contact
- Doors will open at 10:30 am
- Please enter through main lobby for registration
- No cost to attend
- Parking available on site
- Conference will be on the first floor